Correlation Between RCI Hospitality and Regeneron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both RCI Hospitality and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RCI Hospitality and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RCI Hospitality Holdings and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on RCI Hospitality and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RCI Hospitality with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of RCI Hospitality and Regeneron Pharmaceuticals.
Diversification Opportunities for RCI Hospitality and Regeneron Pharmaceuticals
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between RCI and Regeneron is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding RCI Hospitality Holdings and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and RCI Hospitality is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RCI Hospitality Holdings are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of RCI Hospitality i.e., RCI Hospitality and Regeneron Pharmaceuticals go up and down completely randomly.
Pair Corralation between RCI Hospitality and Regeneron Pharmaceuticals
Given the investment horizon of 90 days RCI Hospitality Holdings is expected to under-perform the Regeneron Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, RCI Hospitality Holdings is 1.07 times less risky than Regeneron Pharmaceuticals. The stock trades about -0.19 of its potential returns per unit of risk. The Regeneron Pharmaceuticals is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest 71,576 in Regeneron Pharmaceuticals on December 25, 2024 and sell it today you would lose (5,476) from holding Regeneron Pharmaceuticals or give up 7.65% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
RCI Hospitality Holdings vs. Regeneron Pharmaceuticals
Performance |
Timeline |
RCI Hospitality Holdings |
Regeneron Pharmaceuticals |
RCI Hospitality and Regeneron Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with RCI Hospitality and Regeneron Pharmaceuticals
The main advantage of trading using opposite RCI Hospitality and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RCI Hospitality position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.RCI Hospitality vs. Brinker International | RCI Hospitality vs. Bloomin Brands | RCI Hospitality vs. BJs Restaurants | RCI Hospitality vs. Dennys Corp |
Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |